Study of SHR-2022 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug called SHR-2022 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic cancer (cancer that has spread) confirmed by lab tests or biopsy.
- You have already tried standard treatments, or you cannot tolerate them, or no standard treatment exists.
- You are 18 to 80 years old.
- You have tumors that can be measured on a scan or exam.
- You are able to do most daily activities on your own (ECOG 0-1).
- Your doctor expects you to live at least 3 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-3821 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests a new drug called SHR-7782 for people with advanced cancers that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
This trial tests an investigational drug called SHR-8203 for people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists. The goal is to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called SHR-1826 for people with advanced solid tumors that have not responded to or are no longer helped by standard treatments. It is an early-phase study (Phase 1) to see if the drug is safe and how well it works.
This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.
This trial tests a new drug, SHR-4506, for people with advanced cancers that have stopped responding to standard treatments or cannot be treated with standard options. It aims to see if the drug is safe and helpful.
Hear when a new Advanced Malignant Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.